{"id":"https://openalex.org/A5125586784","orcid":"https://orcid.org/0009-0004-4153-0208","observed_orcids":["https://orcid.org/0009-0004-4153-0208"],"display_name":"Minji Kim","raw_author_names":["Minji Kim"],"full_name":"Minji Kim","works_count":3,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":0.6666666666666666,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5125586784","orcid":"https://orcid.org/0009-0004-4153-0208","observed_orcids":["https://orcid.org/0009-0004-4153-0208"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210148737","ror":"https://ror.org/04yka3j04","display_name":"CHA University","country_code":"KR","type":"education","lineage":["https://openalex.org/I4210148737","https://openalex.org/I4405258985"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I4210148737","ror":"https://ror.org/04yka3j04","display_name":"CHA University","country_code":"KR","type":"education","lineage":["https://openalex.org/I4210148737","https://openalex.org/I4405258985"]}],"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","count":1,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","count":1,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":1,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","count":1,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","count":1,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":5.3e-06,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","value":5.2e-06,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","value":4.4e-06,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","value":4e-06,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8205000162124634},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.7129999995231628},{"id":"109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","score":0.42179998755455017},{"id":"100293340","wikidata":"https://www.wikidata.org/wiki/Q3895235","display_name":"Hildebrand solubility parameter","score":0.4163999855518341},{"id":"107054158","wikidata":"https://www.wikidata.org/wiki/Q25257","display_name":"Precipitation","score":0.2565000057220459}],"counts_by_year":[{"year":2026,"works_count":3,"oa_works_count":2,"cited_by_count":2}],"display_name_alternatives":["Minji Kim"],"block_key":"m kim","works_api_url":"https://api.openalex.org/works?filter=author.id:A5125586784","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2026-02-11T00:00:00"}